Trigenic neural crest-restricted Smad7 over-expression results in congenital craniofacial and cardiovascular defects  by Tang, Sunyong et al.
Developmental Biology 344 (2010) 233–247
Contents lists available at ScienceDirect
Developmental Biology
j ourna l homepage: www.e lsev ie r.com/deve lopmenta lb io logyTrigenic neural crest-restricted Smad7 over-expression results in congenital
craniofacial and cardiovascular defects
Sunyong Tang a,b,1, Paige Snider a,1, Antony B. Firulli a, Simon J. Conway a,b,⁎
a Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA
b Department of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA⁎ Corresponding author. 1044 West Walnut Stree
University School of Medicine, Indianapolis, IN 46202, U
E-mail address: siconway@iupui.edu (S.J. Conway).
1 These authors contributed equally to this work.
0012-1606/$ – see front matter © 2010 Elsevier Inc. A
doi:10.1016/j.ydbio.2010.05.004a b s t r a c ta r t i c l e i n f oArticle history:
Received for publication 2 February 2010
Revised 30 April 2010
Accepted 3 May 2010
Available online 8 May 2010
Keywords:
Mouse embryo
Smad7
Neural crest
Endocardial cushions
Heart development
Facial cleft
Reverse tetracycline transactivator
Tetracycline-responsive element-driven
transgenesSmad7 is a negative regulator of TGFβ superfamily signaling. Using a three-component triple transgenic
system, expression of the inhibitory Smad7 was induced via doxycycline within the NCC lineages at pre- and
post-migratory stages. Consistent with its role in negatively regulating both TGFβ and BMP signaling in vitro,
induction of Smad7 within the NCC signiﬁcantly suppressed phosphorylation levels of both Smad1/5/8 and
Smad2/3 in vivo, resulting in subsequent loss of NCC-derived craniofacial, pharyngeal and cardiac OFT
cushion cells. At the cellular level, increased cell death was observed in pharyngeal arches. However, cell
proliferation and NCC-derived smooth muscle differentiation were unaltered. NCC lineage mapping
demonstrated that cardiac NCC emigration and initial migration were not affected, but subsequent
colonization of the OFT was signiﬁcantly reduced. Induction of Smad7 in post-migratory NCC resulted in
interventricular septal chamber septation defects, suggesting that TGFβ superfamily signaling is also
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Neural crest cells (NCC) are a transient population created during
higher vertebrate early embryonic development. During neurulation,
NCC undergo successive epithelial-to-mesenchymal transformation
(EMT) along a cranial–caudal embryonic axis (Serbedzija et al., 1992),
delaminate and migrate down deﬁned pathways to contribute to the
formation of a wide variety of target tissues; including neurons and
glia of the peripheral nervous system, melanocytes, smooth muscle
cells and most craniofacial cartilages and bones (Nichols, 1981; Le
Douarin and Kalcheim, 1999; Chai et al., 2000). NCC also contribute
crucial cell populations to several thoracic tissues, including the
developing aortic arch arteries (AAA) and outﬂow tract septum (OFT)
of the heart (Kirby and Waldo, 1995; Jiang et al., 2000; Gittenberger-
de Groot et al., 2005; Snider et al., 2007). Despite the diversity of NCC
fates, they are divided broadly into cranial, cardiac and trunk NCC
populations based on their site of origin and ability to colonize
adjacent tissues and organs (Osumi-Yamashita et al., 1994; Kirby and
Waldo, 1995; Kanzler et al., 2000; Helms et al., 2005). This loose
anatomical classiﬁcation of the NCC subpopulations reﬂects the factthat the molecular mechanisms underlying the determination,
pathway-dependent control and morphogenesis of the in utero NCC
types remain far from clear.
TGFβ superfamily members include Activins, BMP and TGFβ
cytokines. Ligands of the TGFβ superfamily are obligatory growth
factors for early embryogenesis and heart morphogenesis, and play
diverse biological roles during cell proliferation, differentiation,
apoptosis and many other tissue remodeling processes. All TGFβ
family members mediate biological function by binding to a receptor
within the cell membrane. BMP signaling (particularly via BMP2,
BMP4 ligands and Alk2, Alk3, Alk4 receptors) has been implicated in
promoting NCC induction, maintenance, migration and differentiation
in several different model organisms (Aybar andMayor, 2002; Knecht
and Bronner-Fraser, 2002; Kaartinen et al., 2004; Stottmann et al.,
2004; Dudas et al., 2004; Morikawa et al., 2009). Similarly, there is
accumulating evidence that TGFβ signaling in NCC is critical, as NCC-
restricted deletion of type I (Alk5) and type II receptors results in a
spectrum of defects in the craniofacial, pharyngeal and cardiac regions
(Choudhary et al., 2006; Wurdak et al., 2005; Ito et al., 2003; Wang et
al., 2006). Signaling is initiated by the binding of ligands to the type II
receptor, which then recruits and activates the type I receptor.
Activated type I receptor then phosphorylates regulatory (R)-Smads
(Smad1, 2, 3, 5 or 8), which form a complex with the co-Smad, Smad4.
The complex then translocates into nucleus to regulate gene
transcription (reviewed by Massagué et al., 2005; Massagué, 2008;
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studies have shown that Wnt1-Cre mediated conditional knockout of
Smad4 within the NCC results in craniofacial, pharyngeal and cardiac
malformations (Jia et al., 2007; Ko et al., 2007; Nie et al., 2008;
Büchmann-Møller et al., 2009). Overall, TGFβ superfamily signaling
has been strongly implicated in NCC development, but its detailed in
utero molecular mechanisms are still poorly understood due to the
large number of family members with wide range of overlapping
functions, genetic compensation, promiscuous receptor–ligand asso-
ciations and functional redundancy. Due to Smad7's unique role in
repressing both BMP and TGFβ signaling and its complementary role
to that of Smad4within TGFβ superfamily signaling, we hypothesized
that Wnt1-Cre mediated Smad7 over-expression would phenocopy
Wnt1-Cre mediated loss of Smad4 function.
To test this assumption and examine further the spatiotemporal
role of TGFβ signaling during NCC morphogenesis and the temporal
consequence of TGFβ superfamily inhibition during development, we
generated a three-component triple transgenic Smad7 expression
mouse model (herein termed trigenic) based on Cre/loxP recombi-
nation (to induce spatially-restricted Smad7) and doxycycline-
inducible control elements (to temporally regulate Smad7). Since
Smad7 has already been demonstrated to negatively regulate both
TGFβ and BMP signaling in vivo in mammalian adult tissues, B cells,
retinal pigment epithelium and Xenopus explant assays (Hayashi et al.,
1997; Nakao et al., 1997; Casellas and Brivanlou 1998; Ishisaki et al.,
1999; Saika et al., 2007), we are using its spatiotemporal induction as
a tool to attenuate TGFβ in utero within restricted cell lineages and
during deﬁned developmental temporal windows. Results reported
here show that pre-migratory Smad7 induction attenuates both TGFβ
and BMP signaling by suppressing R-Smad phosphorylation, resulting
in elevated NCC death, diminished NCC colonization of craniofacial,
pharyngeal, cardiac tissues, dysregulated epithelial–mesenchymal
interactions and in utero lethality. Additionally, Smad7 induction in
post-migratory cardiac NCC results in isolated interventricular septal
defects and neonatal lethality. This work demonstrates that tightly
regulated TGFβ superfamily signaling plays an essential role during
both craniofacial and cardiac NCC colonization and cell survival in
vivo.
Materials and methods
Conditional neural crest-speciﬁc trigenic mice
In the construct used to generate (tetO)-Smad7 transgenic mice,
myc-tagged Smad7cDNA (Kuang et al., 2006) was inserted between a
(tetO)7×CMV minimal promoter and the bovine growth factor
polyadenylation signal sequence (bGHpA) within the pUHD10-3
vector (generously provided by Dr. Andras Nagy, Samuel Lunenfeld
Research Institute; Belteki et al., 2005). Following diagnostic
restriction digest veriﬁcation and sequencing, the linearized construct
was given to the IU Transgenic Core Facility for microinjection into
inbred C3HeB/FeJ zygotes to obtain transgenic founders as described
(Snider et al., 2009). Forward primer 5′-ATCCACGCTGTTTTGACCTC-3′
and reverseprimer5′-GAGCGCAGATCGTTTGGT-3′wereused forgeno-
typing tetO-Smad7 transgenic offspring via PCR using mouse genomic
DNA from tail using established protocols (Snider et al., 2008). Three
independent lines were generated and all three were viable up to
two years of age. In order to generate triple transgenic doxycycline-
inducible mice, tetO-Smad7 mice were intercrossed with both the
reverse tetracycline transactivator Rosa26rtTA–EGFP (R26rtTA–EGFP) (Jax-
Lab stock #005670) and Wnt1-Cre (Jiang et al., 2000) mice. For the
lineage mapping studies, Rosa26 reporter (R26r) mice (JaxLab stock
#003474) were intercrossed with the trigenics. Genotyping was
carried out using PCR primers speciﬁc for each transgene (http://
www.jax.org; Jiang et al., 2000). All mice were maintained on mixed
genetic backgrounds and age-matched littermates were used asappropriate controls. To induce Smad7 transgene expression in
trigenic embryos, pregnant females were given doxycycline adminis-
tered in green dyed food pellets at a concentration of 200 mg/kg (Bio-
Serv; Frenchtown, NJ) for speciﬁed time periods. Mice were main-
tained under speciﬁc-pathogen-free conditions with a 12 h light/dark
cycle. The animal use protocols were approved by the Institutional
Animal Care and Use Committee at IUPUI (study #3301).
RNA and protein analysis
In order to verify Smad7 cDNA induction by RT-PCR, cDNA was
synthesized from RNA isolated from individual control (trigenic mice
without doxycycline food) and mutant (trigenic mice feed doxycy-
cline food) embryonic day 10.5 (E10.5) whole embryos (n=4
embryos of each treatment) using a Superscript-II kit (Invitrogen)
with 5 μg RNA and oligo(dT) primer. cDNAs were ampliﬁed with
speciﬁc Smad7 primers (30 cycles; forward primer 5′-GCATTCCTCG-
GAAGTCAAGA-3′ and reverse primer 5′-TTGTTGTCCGAATTGAGCTG-
3′) and normalized with GAPDH (16 cycles; Glyceraldehyde-3-
phosphate dehydrogenase) as described previously (Rios et al., 2005).
In order to verify myc-tagged Smad7 protein induction and
suppressive effects upon TGFβ superfamily signaling via Western
blotting, doxycycline-fed E10.5 embryos were homogenized on ice in
RIPA buffer with 1% phosphatase inhibitor mixture (Sigma). Proteins
were blotted onto PVDF membrane and the following antibodies
used; Smad1 (1:2000 dilution Santa Cruz Biotech, sc-81378),
phospho-Smad1/5/8 (1:1000 dilution cell signaling, 9511), Smad2/
3 (1:2000 dilution Santa Cruz Biotech, sc-8332), phospho-Smad2
(1:1000 dilution cell signaling, 3101), Myc (1:5000 dilution Santa
Cruz Biotech, A-14), αTubulin (1:10,000 dilution Sigma, T-5168).
Primary antibody binding was visualized by HRP-conjugated second-
ary antibodies and enhanced chemiluminescence (Amersham, GE
Healthcare Biosciences). Signal intensity was quantiﬁed from at least
3 samples by Image J (http://rsweb.nih.gov/ij/) and the combined
data graphically displayed.
Histological analysis, X-Gal staining and immunohistochemistry
Tissue isolation, 4% paraformaldehyde ﬁxation, processing, paraf-
ﬁn embedding, H&E staining, and whole mount detection of R26r
indicator β-galactosidase activity were performed as described (Rios
et al., 2005; Snider et al., 2008, 2009). Sections (n=3 individual
embryos of each genotype) were cut at 10 μm thickness and
counterstained with Eosin. As our mice lines are not isogenic,
doxycycline-fed non-trigenic single and double transgenic age-
matched littermates were used as negative controls.
Immunostaining was carried out using ABC kit (Vectorstain) with
DAB and hydrogen peroxide chromogens as described previously
(Zhou et al., 2008). The following primary antibodies were used to
assess neural crest differentiation and TGFβ superfamily signaling: α-
smooth muscle actin (1:5000 dilution αSMA; Sigma), phospho-
Smad1/5/8 (1:750 dilution Cell Signaling, 9511), phospho-Smad2
(1:1500 dilution Cell Signaling, 3101). Negative controls were
obtained by substituting the primary antibody with serum at 1:150
dilution and positive staining within serial sections was examined
using at least three individual embryos of each genotype at each
developmental stage.
Apoptosis and cell proliferation
Apoptotic cells were detected in parafﬁn-embedded tissue sections
using TdT-FragEL™ DNA Fragmentation Detection Kit (Calbiochem).
Cell proliferation was immunodetected using Ki67 antibody (1:25
dilution DakoCytomation, CA). Both assays were performed on par-
afﬁn serial sections (n=4). Both trigenic and control sections were
placed on the same slides, thus receiving identical processing and
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were counted manually in deﬁned areas of tissues under 40×
magniﬁcation. Statistical analysis of cell counts in serial sections and
comparison of mutant specimens with controls was performed using
one-tailed Student's t test (P values were assigned, with 0.05 being
signiﬁcant).
In situ hybridization
Radioactive in situ hybridization for Ap2α Crabp1, Fgf8, Msx1,Msx2,
Pax3 and Sox10 expression was performed as described (Conway et
al., 1997, 2000; Snider et al., 2009). Both sense and antisense
35
S-UTP-
labeled probes were used, and speciﬁc signal was observed only with
hybridization of the antisense probe, in serial sections within at least
three independent embryos of each genotype. In order to quantitate
expression differences, silver grains were counted/cell on serial
sections and comparison of mutant specimens with controls was
performed using one-tailed Student's t test.Fig. 1. Evaluation of the trigenic Cre/loxP-dependent, tetracycline inducible transgenic syste
mice will only express the rtTA from the Rosa26 locus upon Cre-mediated recombination (B
including the cardiac and craniofacial NCC lineages (Jiang et al., 2000; Chai et al., 2000). In t
Smad7 cDNA) is under the control of heptamerized tetOn promoter, but Smad7 is not express
same cell. Although all three transgenes are individually silent within the compound trigen
lineages upon doxycycline feeding. Thus, the spatiotemporal timing of myc-tagged Smad7 e
expression of Cre recombinase. (B) RT-PCR analysis reveals that Smad7 mRNA expression i
control embryo expression of endogenous Smad7 (n=4 embryos of each genotype). Loadin
that myc-Smad7 is only expressed within duplicate doxycycline-fed duplicate trigenic E10.5
duplicates). The presence of myc-Smad7 suppressed both pSmad1/5/8 and pSmad2 levels
littermates, indicating over-expression of Smad7 attenuates both BMP and TGFβ signaling
signal was detected after 5 s, while Myc and Smads was after 30 s exposures. AbbreviationResults
Generation of neural crest-restricted inducible Smad7 mouse line
In order to spatially restrict Smad7 over-expression to the NCC
lineages, we used theWnt1-Cre transgenic driver line (Fig. 1A) (Brault
et al., 2001; Chai et al., 2000; Jiang et al., 2000; Stottmann et al., 2004;
Snider et al., 2007). Temporal regulation of the onset of Smad7 within
the NCC was achieved with the inducible reverse tetracycline
transactivator (rtTA). The Rosa26rtTA–EGFP mice contain the rtTA with
a nuclear localization signal targeted into the Rosa26 locus, and a
downstream EGFP separated by an IRES sequence to ensure efﬁcient
EGFP translation (Fig.1A). The ROSA locus has been shown to be
expressed in all cell types at all developmental and postnatal stages,
and its expression is not subject to genetic or environmental changes
(Zambrowicz et al., 1997). In the absence of its inducer doxycycline (a
derivative of tetracycline), rtTA does not recognize its DNA binding
sequence, tetO. On the other hand, addition of doxycycline allows rtTAm. (A) Schematic illustrating operation of the trigenic system. The R26rtTA–EGFP knockin
elteki et al., 2005).Wnt1-Cre transgenic mice have been shown to label almost all NCC,
he tetO-Smad7 transgenic mice, myc-Smad7 full length cDNA (myc tag is blue box 5′ of
ed until both the transactivator (rtTA) and inducer (doxycycline) are present within the
ic mice, myc-tagged Smad7 can be speciﬁcally induced within Cre-positive neural crest
xpression is determined by the timing of doxycycline addition and positionally by the
s upregulated ∼10 fold in trigenic E10.5 embryos fed doxycycline at E7.5 compared to
g was normalized using GAPDH housekeeping control. (C,D) Western analysis veriﬁes
embryos fed doxycycline at E7.5, and is absent from duplicate control embryos (n=3
relative to total Smad1 and pSmad2/3 levels when compared to age-matched control
by ∼55% (D). Loading was normalized using Tubulin housekeeping control. αTubulin
s: tri, trigenic tetO-Smad7/Wnt1-Cre/RosartTA–EGFP embryos; con, control embryos.
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tetO-Smad7 transgene (Fig. 1A). Furthermore, as the rtTA expression
module is preceded by a ﬂoxed STOP expression cassette, rtTA
expression is dependent upon Cre/loxP recombinase to remove the
loxP-ﬂanked STOP expression cassette from within the R26 locus. The
R26rtTA–EGFP mice have previously been shown to drive robust
expression of doxycycline-inducible tetO-controlled transgenes (Bel-
teki et al., 2005). TetO-Smad7 transgenic mice (three separate lines)
were generated by placing full length Smad7 cDNA under the control
of heptamerized tetO promoter (Fig. 1A). As there are no commer-
cially-available speciﬁc Smad7 antibodies available and in order to
unequivocally detect transgenic Smad7 protein in vivo, we used a
myc-tagged Smad7, as this cDNA has already been demonstrated to
block TGFβ signaling in vivo in adult transgenic mice (Kuang et al.,
2006). Utilizing our R26rtTA–EGFP/tetO-Smad7/Wnt1-Cre trigenic mice,
we can control temporal induction of in utero NCC-restricted myc-
Smad7 by feeding doxycycline-containing food to the pregnant
mother (Fig. 1A); and in non-NCC lineages the tetO-Smad7 is silent.
Inducible over-expression of Smad7 in vivo
In order to verify the “silent but inducible” feature of our trigenic
system, we placed each of the three individual TetO-Smad7 target
mouse lines onto an R26rtTA–EGFP/Wnt1-Cre genetic background to
generate R26rtTA–EGFP/tetO-Smad7/Wnt1-Cre trigenic mice. Male tri-
genic offspring were then crossed to homozygous female R26rtTA–EGFP
mice (fed regular chow) and resultant trigenic embryos examined for
myc-Smad7 protein and Smad7 mRNA overexpression. To simulta-
neously detect both endogenous and transgenic Smad7 mRNA, both
forward and reverse primers located within the Smad7 cDNA
transcript were employed. As expected, normal litter sizes (n=8
embryos/litter from 10 litters) and trigenic offspring were recovered
at expected Mendelian ratios when harvested at E14.5 (data not
shown). Additionally, neither Western analysis nor RT-PCR detected
myc-Smad7 protein or elevated Smad7 mRNA expression in normal
fed trigenic embryos (data not shown).
When the food was switched from regular to doxycycline-
containing food, both myc-Smad7 protein induction and elevated
Smad7 mRNA expression were observed speciﬁcally within trigenic
embryos (Figs. 1B,C). Signiﬁcantly, feeding pregnant females doxycy-
cline at E10.5 gestation resulted in both Smad7 mRNA upregulation
(8x fold) and myc-Smad7 induction in E11.5 trigenic whole embryos
but not within control (remaining allelic single and double transgenic
combinations) littermates (not shown). This rapid induction is
consistent with other studies that have shown rtTA-driven transgene
expression is detectable with adult lungs 6–12 after doxycycline (Perl
et al., 2002). Additionally, the relative level of myc-Smad7 induction is
comparable to the 3× fold elevation in aged skin and 4× fold elevation
in some tumors (Han et al., 2006). Without doxycycline administra-
tion to the mother, these embryos develop normally and reach
adulthood (not shown). As expected feeding pregnant females
doxycycline from E7.5 gestation onwards also resulted in Smad7
mRNA upregulation (10× fold) in E10.5 trigenics relative to littermate
controls (Fig. 1B). Similarly, myc is detected within trigenic E10.5
mutants only after being fed doxycycline (Fig. 1C). As similar levels of
myc-Smad7 induction were observed using all three independent
trigenic lines (not shown), results from just one line are presented to
simplify data. Since Smad7 has been shown to negatively regulate
both TGFβ and BMP signaling in vitro (Hayashi et al., 1997), we
examined whether myc-Smad7 induction attenuated both phosphor-
ylated Smad1/5/8 (pSmad1/5/8) and phosphorylated Smad2/3
(pSmad2/3) levels in vivo. Western analysis reveals that pSmad1/5/
8 levels were reduced by 55.5% (Pb0.037) and pSmad2 levels were
reduced by 58.3% (Pb0.021) in whole body doxycycline-fed trigenic
E10.5 mutants (Figs. 1C,D). Similarly, when just NCC-enriched
craniofacial and 1st pharyngeal arch tissues were used (SupplementalFig. 1), the presence of myc-Smad7 suppressed both pSmad1/5/8 (by
∼72%) and pSmad2 (by ∼85%) levels relative to total Smad1 and
Smad2/3 levels compared to age-matched control tissues. Combined,
these data demonstrate that transgenic Smad7 expression is tightly
controlled in this three-component genetic system, and that myc-
Smad7 expression is induced rapidly in NCC-derived tissues by
application of doxycycline to the system and the induced myc-Smad7
represses both TGFβ and BMP signaling in vivo. In addition, when
doxycycline was administered to wild type pregnant females
throughout gestation starting at E6, normal litter sizes (n=8
embryos/litter from 6 litters) were recovered postnatally, demon-
strating that sustained doxycycline does not adversely affect in utero
morphogenesis.
Over-expression of Smad7 in the neural crest impairs normal
craniofacial and pharyngeal arch development
During craniofacial development, cranial NCC migrate ventrolat-
erally as they populate the craniofacial region. The proliferative
activity of cranial NCC produces the frontonasal process and the
discrete swellings that demarcate each branchial arch (Chai et al.,
2000). In order to examine the early effects upon NCCmorphogenesis,
we induced myc-Smad7 transgene expression beginning E7.5 (early
headfold pre-somitic stage), as this is prior to the onset of Wnt1-Cre
expression (Stottmann et al., 2004) and NCC emigration from the
neural tube (Nichols, 1981; Serbedzija et al., 1992; Kirby and Waldo,
1995; Le Douarin and Kalcheim, 1999; Snider et al., 2007). NCC
lineage tracing experiments with Wnt1-Cre and the Rosa26 reporter
(R26r; Soriano, 1999) show expression starts in the rostral hindbrain
around the four somite (E8.0) stage and extends to the midbrain,
forebrain and caudal hindbrain, and progresses to increasingly caudal
cardiac and trunk levels by eight somite (E8.5) stages (Stottmann et
al., 2004). Thus, Wnt1-Cre allows recombination of ﬂoxed STOP
R26rtTA–EGFP rtTA expression within the NCC from very early stages of
its development.
To examine the effects of Smad7 over-expression and to directly
test the in vivo requirement of regulated TGFβ superfamily signaling
during early NCC morphogenesis in utero, we fed pregnant trigenic
females doxycycline from E7.5 onwards. Resultant embryos were
harvested at E9 to birth. Initially, E9 trigenic embryos were
indistinguishable from control littermates, but by E10 the trigenics
were slightly smaller and exhibit subtle craniofacial and pharyngeal
arch dysplasia defects (Figs. 2A–C). Speciﬁcally, the 1st pharyngeal
arch was hypoplastic and the face/forebrain region was undersized.
This became more evident at E11.5, as all the trigenic embryos
exhibited signiﬁcantly smaller craniofacial regions (n=7/7 trigenics
exhibit craniofacial defects) and greatly reduced 1st, 2nd and 3rd
pharyngeal arches (Figs. 2D–F). By E13.5, the trigenic embryos grossly
lacked identiﬁable upper and lower jaws (Figs. 2G–I) but were
otherwise viable until birth. However, none of the doxycycline-fed
trigenic offspring were recovered at birth (n=7 litters). The non-
trigenic littermates with remaining allelic combinations were phe-
notypically normal and serve as genetic background, age-matched
and doxycycline-exposure controls. Histology revealed that the upper
and lower jaws were indeed hypoplastic and the tongue was reduced
in size, but Meckel's cartilage, which forms a template for mandible
formation and is derived from cranial NCC (Chai et al., 2000) was still
present (Fig. 3B). These data are consistent with the underdevelop-
ment of medial nasal prominences and incomplete tongue formation
observed inWnt1-Cre;Smad4loxp/loxp embryos (Ko et al., 2007; Jia et al.,
2007). Histology also revealed that 100% E13.5 trigenic mutants
(n=5) lack the choroid plexus that extends into the fourth ventricle,
even though the choroid plexus extending into the lateral ventricle
was present (Fig. 3B). As X-Gal staining of Wnt1-Cre;R26r brains has
shown that recombination of the R26r allele is conﬁned to the CNS
midbrain, hindbrain and cerebellum & choroid plexus in 4th vent/
Fig. 2. Early Smad7 induction within the neural crest lineage suppresses normal craniofacial and pharyngeal arch development. (A-C) E10.0 control and trigenic (right embryo in A)
whole embryos fed doxycycline at E7.5 appear grossly similar except smaller facial processes, but higher magniﬁcation reveals that the mandibular component of the E10.0 trigenic
mutant 1st pharyngeal arch is undersized and the oropharyngeal region below the nasal process is enlarged (indicated by * in C) when compared to age-matched control (B). (D-F)
E11.5 control and trigenic (right embryo in D) whole embryos. Note trigenic 1st and 2nd arches are dramatically underdeveloped and the facial processes are hypoplastic (F) when
compared to controls (E), but the size of the trigenic heart appears is unaffected. (G-I) E13.5 control and trigenic (right embryo) whole embryos fed doxycycline at E7.5. Note in
isolated heads (severed immediately below lower jaw), both the upper and lower jaws of the trigenic mutant are severely hypoplastic and largely absent (I) when compared to
control littermates (H). Abbreviations: 1, ﬁrst pharyngeal arch; 2, second pharyngeal arch; a, atrium; v, ventricle; lv, left ventricle; e, eye. Bar in A=0.1 mm; B,C=0.05 mm.
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present within the migrating cranial NCC, meninges, and choroid
plexus (Wang et al., 1995); this selective loss of the choroid plexus
that extends into the fourth ventricle was directly due to the
restricted Smad7 overexpression within the NCC that contribute to
this particular choroid plexus. As cranial NCC, located at the anterior
neural tube are the ﬁrst NCC population to migrate and populate the
1st, 2nd and 3rd pharyngeal arches and frontonasal mass, it is not
surprising that these are the NCC lineage most visibly affected.
Induced Smad7 over-expression impairs normal cardiac development
As trigenic mutants fed doxycycline from E7.5 onwards were not
recovered at birth and Wnt1-Cre:R26r marked NCC have been shown
to be essential for heart morphogenesis (reviewed by Kirby and
Waldo, 1995; Snider et al., 2007), we examined the effects of NCC-
restricted over-expression of Smad7 within the cardiovascular
system. Cardiac NCC migrate through 3rd, 4th and 6th pharyngeal
arches to colonize the OFT cushions, where they are required for
septation of the truncus arteriosus into the aorta and pulmonaryartery (Kirby and Waldo, 1995; Conway et al., 2003). Histology
revealed that all trigenic mutants exhibit OFT defects (n=11/11
trigenics fed doxycycline at E7.5), speciﬁcally a single outlet forming
persistent truncus arteriosus (PTA). Besides a failure of OFT
separation, the right subclavian in trigenic embryos was retro-
esophageally located (Fig.3D) and the outlet valve leaﬂets were
abnormally thickened (Fig. 3F), when compared to those seen in the
control embryos (Figs. 3C,E). Additionally, trigenic embryos present
accompanying membranous interventricular septal defects (VSD)
(Fig. 3H). However, trigenic dorsal root ganglia and thymus appeared
largely unaffected relative to the overall embryo size (Figs. 3J,L),
notwithstanding having a NCC contribution (Jiang et al., 2000).
Furthermore, trigenic dorsal root ganglia were normally colonized via
NCC lineage (Fig. 4) and appropriately expressed Ap2α , Crapb1 and
Sox10 mRNA (not shown).
Neural crest lineage mapping reveals regional deﬁciencies
To verify Wnt1-Cre recombination efﬁciency in trigenics and to
determine the origin of these defects, trigenic mice NCC were lineage
Fig. 3. Histological examination of E13.5 Smad7 trigenic phenotypes fed doxycycline at E7.5. (A,B) Control and trigenic littermate cranial regions sectioned sagittally and stained with H&E. Note the absent ventral extremity of the lower jaw
and lip, hypoplastic tongue, absent primary palate, and absent upper jaw and lip in trigenic mutant (* in B). However, Meckel's cartilage is still present in the mutant (yellow arrowhead). Whilst the choroid plexus (cp) extending into the
trigenic lateral ventricle is present, the choroid plexus differentiating from the roof of the fourth ventricle is absent (arrow in B). (C-H) Low power images of serial sagittal sections through control (C,E,G) and trigenic (D,F,H) cardiothoracic
regions at the level of the OFT and high power images of the interventricular septum (G,H).While the control has separate ascending aorta and pulmonary trunk vessels (C,E), the trigenic mutant outﬂow tract has failed to septate and remains
as a single outlet (PTA; E) and the right subclavian is retroesophageally located in the trigenic embryo (arrow in D). Additionally, the trigenic embryo exhibits accompanying interventricular septal defects (H). (I-L) Higher power images of
transverse sections reveal that both the trigenic dorsal root ganglia (J) and thymus (L) are histologically normal when compared to control littermates (I,K), but are proportionately smaller in line with the overall reduced size of the trigenics.
Abbreviations: t, tounge; nt, neural tube; PTA, persistent truncus arteriosus; VSD, Ventricular Septum Defect; sep, septum; rv, right ventricle; lv, left ventricle; la, left ventricle; Ao, aortic trunk; dAo, descending aorta; p, pulmonary trunk; drg,
dorsal root ganglia; thy, thymus; X, vagal X trunk. Bars in I,J=10 μm.
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239S. Tang et al. / Developmental Biology 344 (2010) 233–247mapped. Earlier studies have shown that elements of TGFβ super-
family signaling are required for normal craniofacial and cardiac NCC
migration. For example, Wnt1-Cre conditional deletion of the
canonical TGFβ factor signaling cofactor Smad4 (Jia et al., 2007; Ko
et al., 2007; Nie et al., 2008; Büchmann-Møller et al., 2009) and
transgenic overexpression of the BMP-antagonist Noggin (Kanzler et
al., 2000) can result in NCC-deﬁciency. Analysis of β-galactosidase
stained trigenic mutant embryos carrying the R26r reporter showed
normal NCC migration and contribution to the craniofacial region and
dorsal root ganglia, but reduced NCC colonization of the OFT itself.
From E10.5-11.5, robust lacZ staining was evident in the frontonasal
prominence, trigeminal nerve ganglia, 1st, 2nd pharyngeal arches
alongwith facial nerve ganglia, and primordium of the 3rd pharyngeal
arch in trigenic embryos (Figs. 4A,C,D), similar to that observed in
controls (Figs. 4A,B,D). Intriguingly, this assay revealed that whereas
the NCC populate the craniofacial and pharyngeal regions, the 1st, 2nd
and facial regions failed to form normally and were hypoplastic in
trigenics (Fig. 2). However, in E13.5 trigenic embryos there were
subsequent lacZ-negative areas of frontonasal mesenchyme, suggest-
ing a subsequent loss of lacZ-positive cells (Figs. 4N). This was
conﬁrmed via histology (not shown). Similar to the cranial NCC,
migration of the lacZ-marked cardiac NCC was largely unaffected in
E10.5 trigenic embryos (Figs. 4A–C), and trunk NCC contribution to
the trigenic dorsal root ganglia was unchanged when compared to
littermate controls (Figs. 4A,D). However, further analysis of cardiac
NCC colonization of the heart shows that although a signiﬁcant
number of NCC have populated the pharyngeal arches and aortic sac,
only a few trigenic NCC colonized the truncal region and there was a
complete lack of colonization of the more proximal conal cushion
region of the trigenic truncus arteriosus (Figs. 4G,H,L) when
compared to control littermates (Figs. 4E,F,K). The foremost difference
of cardiac NCC contribution to the trigenic OFT embryos could also be
seen at later stages (Fig. 4P). The difference between the presence of
fully penetrant OFT defects and dramatically reduced cardiac NCC
colonization and unaffected NCC contribution to the dorsal root
ganglia and normal cranial NCC migration patterns, suggests that the
cardiac NCC population and morphogenesis of the OFT are especially
sensitive to suppression of TGFβ superfamily signaling. Furthermore,
lineage mapping established that Smad7-mediated suppression of
TGFβ superfamily signaling principally inhibits later cardiac NCC
colonization of the OFT, rather than early NCC emigration and
migration from the neural tube.
Trigenic mutants exhibit normal proliferation but increased cell death
Such dramatic changes in the morphology of the frontonasal and
OFT tissues could be accomplished via a change in the amount of cell
death and/or cell proliferation. Cell proliferation assays, using Ki67 to
mark cells in all active phases of the cell cycle (G1, S, G2, and mitosis)
in sectioned E10.5 trigenic embryos fed doxycycline from E7.5
onwards, did not detect any decrease in facial, 1st pharyngeal arch
mesenchyme or OFT cushion cell proliferation index (Figs. 5A–C).
Total E10.5 1st pharyngeal arch proliferation in trigenic mutants was
reduced (∼675 Ki67 positive cells/arch/10 μm section) when com-
pared to age-matched control embryos (∼1003 Ki67 positive cells/
arch/10 μm section), due to the hypoplastic trigenic phenotype. This
was speciﬁcally apparent at the base of the 1st trigenic arch (Fig. 5B),
where the mesenchyme was sparse compared to control littermates.
However, when proliferating cells were tallied (as a percentage of
total cells in the 1st pharyngeal arch) to calculate a mitotic index,
there was no signiﬁcant difference by this measure (90.9% in controls
versus 91.2% in trigenics). Thus, the defects in mutant embryos were
unlikely to be caused by reduced NCC proliferation.
In contrast, using the TUNEL assay to mark apoptotic cells,
dramatic increases in cell death in the E10.5 trigenic facial and
pharyngeal arch mesenchyme and within migratory NCC lineageswere observed (Figs. 5D–F). Considerable and aberrant cell death was
localized to the trigenic facial primordia and 1st (Fig. 5E), 2nd and 3rd
pharyngeal arches of mutant embryos, but not within the OFT
cushions nor the cardiomyocytes of the heart or the neuroepitheium
(not shown). The sparse mesenchyme at the base of the 1st trigenic
arch still contained several apoptotic cells, but is adjacent to a region
of very robust apoptosis (Fig. 5E). TUNEL staining of older E11 and
E11.5 embryos revealed that the entire 1st arch mesenchyme was
sparse and apoptotic (not shown), suggesting that apoptosis initiates
at the base of the arches and progresses more ventrally as development
proceeds. When TUNEL positive cells were tallied as a percentage of
total cells in the 1st arch to calculate a cell death index, there was a
signiﬁcant increase in cell death (1.55% in controls versus 16.52% in
trigenics; Pb0.001). To test if these apoptotic cells were limited to NCC,
we performed X-gal staining on E11.0 trigenic; R26r embryos to label
NCC and their derivatives followed by TUNEL (Fig. 5G). As expected,
manyNCCwere positively stainedwith the TUNEL signal. These data are
consistent with the dramatic increases in cell death observed inWnt1-
Cre;Smad4loxp/loxp (Ko et al., 2007; Jia et al., 2007; Nie et al., 2008;
Büchmann-Møller et al., 2009) and Wnt1-Cre;Alk5loxp/loxp embryos
(Wang et al., 2006), as both Smad4 and Alk5 are required for survival
of cardiac NCC. Similarly,Wnt1-Cre;Alk3loxp/loxp embryos exhibit normal
NCC migration, but NCC subpopulations die immediately after coloni-
zation of their target tissues (Morikawa et al., 2009). Intriguingly, loss of
BMP antagonists (Noggin and Chordin) results in excessive NCC
emigration from the neural tube that results in elevated NCC-restricted
apoptosis (Anderson et al., 2006). Combined, these data reveal that
Smad7 suppression of TGFβ superfamily signaling within early NCC is
required for normal survival of migratory NCC-derived mesenchyme
and furthermore demonstrate that combined suppression of TGFβ and
BMP pathways, deletion of either individual TGFβ or BMP pathway
effectors or increased BMP signaling can all likewise distress NCC
survival in vivo.
Aortic arch artery remodeling is unaffected
Given the frequent association of anomalous pharyngeal AAA
remodeling and pathogenesis of OFT defects (Kirby and Waldo, 1995;
Conway et al., 2000; Stalmans et al., 2003; Snider and Conway, 2007)
we used histology and α-smooth muscle actin (αSMA) to determine
whether AAA were properly formed in myc-Smad7 trigenic mutants
fed doxycycline from E7.5 onwards (Figs. 5H–K). This analysis
revealed the trigenic AAA were present and patent by E10.5,
suggesting that induction of Smad7 in NCC does not disrupt initial
arch artery formation. However, αSMA staining of the OFT cushions
was reduced in E10.5 mutants, and as colonizing cardiac NCC express
αSMA (Epstein et al., 2000), these results conﬁrm the reducedWnt1-
Cre;R26r lineage mapping data in trigenic OFT cushions (Fig. 4). We
further examined whetherαSMA positive NCC-derived cells ensheath
the remodeled trigenic AAA. Both the control and trigenic 4th and 6th
AAA were intact and exhibit similar αSMA expression patterns
(Figs. 5J,K). Despite suppression of TGFβ signaling within NCC lineage,
we did not observe abnormal regression of AAAs, a defect which was
reported in Wnt1-Cre;Alk2loxp/loxp and Wnt1-Cre;Alk5loxp/loxp embryos
(Kaartinen et al., 2004; Wang et al., 2006)
Localized attenuated TGFβ and BMP signaling
To further resolve themolecular defects in trigenic mutants caused
by NCC-restricted induction of Smad7, we examined the spatial
expression of both pSmad1/5/8 and pSmad2 in trigenic and control
embryos fed doxycycline from E7.5 onwards. Consistent withWestern
data (see Figs. 1C,D and Supplemental Fig. 1), pSmad1/5/8 and
pSmad2 expression was reduced in E10.5 trigenic embryo NCC
lineages compared to control littermates (Fig. 6). Signiﬁcantly
reduced numbers of pSmad1/5/8-positive and pSmad2-positive
240 S. Tang et al. / Developmental Biology 344 (2010) 233–247cells were detected in the mesenchyme and ectoderm-derived
epithelium of the trigenic frontal facial region (Figs. 6B,J) and
pharyngeal arches (Figs. 6D,L), and within the aortic sac mesenchyme(Figs. 6F,N), but not in the trigenic ventricular myocardium/
epicardium/endothelium (Figs. 6H,P). Each of the mesenchymal
sites of reduced pSmad1/5/8 and pSmad2 expression correlate with
241S. Tang et al. / Developmental Biology 344 (2010) 233–247Wnt1-Cre;R26r lineage mapped NCC (Fig. 4; Chai et al., 2000; Jiang et
al., 2000), indicating that both TGFβ and BMP signaling were
signiﬁcantly attenuated within NCC in vivo by over-expression of
myc-Smad7. However, both normal (Chai et al., 2000) and Smad7
overexpressing ectoderm-derived epithelium (Fig. 4) are completely
free of NCC progeny, suggesting that NCC migration and colonization
were unaffected, suggesting a bystander effect. These immunohisto-
chemical data are consistent with the signiﬁcantly reduced pSmad
levels detected via whole body and NCC-enriched Westerns, as we
observe almost 100% suppression within NCC-speciﬁc tissues.
Altered gene expression in pharyngeal arches in mutant embryos
To investigate the signaling mechanism of Smad7 induction in
regulating epithelial–mesenchymal interactions; we examined ex-
pression patterns of genes expressed in the early trigenic (fed
doxycycline from E7.5 onwards) neural tube, in migratory NCC, and
genes known to be critical for early mandible development. We ﬁrst
examined expression of different NCCmarkers including Pax3, Crapb1,
Ap2α, Msx1 and Msx2 in E9 embryos by in situ hybridization analysis.
Pax3 transcription factor is required for normal OFT development and
is expressed within the early dorsal neural tube prior to NCC
emigration and during initial migration from the neural tube (Conway
et al., 1997; Epstein et al., 2000), whileMsx2 transcription factor is co-
expressed with Pax3 within the neural tube and is an immediate
downstream effector of Pax3 in the cardiac NCC (Kwang et al., 2002).
Msx2, a homeobox gene regulating BMP signaling, can act in concert
with Msx1 to regulate cranial NCC differentiation (Han et al., 2007).
Both Crabp1 and Ap2α transcription factor are retinoic acid responsive
genes that are expressed in migrating NCC (Conway et al., 1997,
2000). We did not observe any obvious abnormal expression of these
genes (not shown), suggesting that the initial formation of NCC was
intact in trigenic embryos. These data are consistent with our Wnt1-
Cre;R26r cell lineage analysis (see Fig. 4).
Next we evaluated expression of the Crapb1 and Ap2α NCC
markers, as well as Fgf8 and Sox10 expression in E10.5-13.5 trigenic
and control embryos fed doxycycline from E7.5 onwards (Fig. 7). In
developmentally older embryos, Ap2α is still expressed within
migratory NCC but is also expressed robustly within the ectoderm
(Brewer et al., 2002). Fgf8 encodes a signaling growth factor molecule
expressed in the epithelia of pharyngeal arches, and is required for
normal growth of pharyngeal arches and remodeling of OFT (Frank et
al., 2002). While the Sox10 transcription factor is essential for the
development of NCC-derived glia and neurons of the peripheral
nervous system (Sonnenberg-Riethmacher et al., 2001). Signiﬁcantly,
expression of Crabp1 (Fig. 7B) and Ap2αwere visibly reduced (but not
eliminated) from their expression domains within E10.5 trigenic
migratory cardiac NCC, whereas expression of CrabpI was not
noticeably affected within non-NCC-derived body wall. Ap2α was
also reduced within trigenic facial mesenchyme, but that most likely
reﬂected apoptotic loss of cranial NCC. Intriguingly, while ectodermalFig. 4. NCC develop in Smad7 trigenic mutant embryos fed doxycycline at E7.5. To lineage m
with Smad7 trigenic to enable us to visualize NCC migration and colonization of the cran
littermates, revealed that initial NCC migration was largely unaffected within the trigeni
littermates. Robust lacZ expression is evident in trigenic frontonasal prominence, trigemina
and primordium of the 3rd pharyngeal arch. Similarly, lacZ-marked NCC are present within
E11.5 trigenic and control littermate whole embryos (D); isolated control (E,F) and trigenic (
control (I) and trigenic (J) craniofacial regions. Note there is a deﬁciency of NCC-derived Schw
(E–H) Higher power views of isolated hearts clearly show that Smad7 trigenic NCC reach t
truncal region but that there are no lacZ stained NCC within the trigenic OFT conal region (*
hypoplastic craniofacial regions, there are reduced numbers of lacZ positive cells, particularly
in J). (K,L) Sections through OFT from distal to proximal in E11.5 control (K, K′, K″) and trige
there are fewer cells within the conal cushions and that themutant NCC are not found in ecto
(M-P) LacZ stained E13.5 control (M,O) and trigenic littermate whole embryos and isolated
craniofacial regions (arrow in N) and the absence of lacZ positive NCC within the trigenic OFT
endocardial cushions; rv, right ventricle; ra, right atria; e, eye. Bars in I,J=0.2 mm.Ap2α expression appeared comparable between control and trigenic
littermates, trigenic 1st arch mesenchyme Ap2α expression was
increased compared to control mesnchyme (Figs. 7C,D). Correspond-
ingly, Fgf8was speciﬁcally elevated within the trigenic 1st pharyngeal
arch and facial ectodermal lineages (Fig. 7F). Counting of silver grains/
cell revealed a ∼4× increase in Fgf8 expression in trigenic (87±11
grains/cell; n=3 embryos, ﬁve 10 μm sections/embryo) versus con-
trol (22±8 grains/cell; n=3 embryos, ﬁve 10 μm sections/embryo)
1st arch ectoderm. Consistent with the normal histology (see Fig. 3J)
and correct NCC-contribution (see Figs. 4A,D); Ap2α, Crapb1 and
Sox10were each expressed normally in E10.5 and 13.5 trigenic dorsal
root ganglia (not shown). Collectively, these results indicate that
suppression of TGFβ superfamily signaling within the cranial and
cardiac NCC, disrupted not only distinct NCC populations gene
expression but also normal developmental processes in neighboring
cell populations. Thus, bystander affects upon neighboring epithelial
TGFβ superfamily signaling may augment the subsequent hypoplasia
of these structures and contribute to the overall pathogenesis of the
severe malformations in trigenic mutant embryos.
Over-expression of Smad7 in the neural crest following OFT colonization
also results in abnormal heart development
To examine the effects of Smad7 over-expression within post-
migratory NCC following colonization of their target tissues, we fed
pregnant trigenic females doxycycline from E10 onwards. Our initial
characterization of the trigenic system revealed that feeding pregnant
females doxycycline at E10.5 gestation resulted in both Smad7mRNA
upregulation and myc-Smad7 induction by E11.5 in only trigenic but
not control littermates (see Fig. 1). Grossly, E14.5 trigenic fetuses
were indistinguishable from control littermates, but histology
revealed that 100% of the E14.5 trigenic mutants exhibit membranous
VSD (n=7/7 trigenics exhibit heart defects; Fig. 8D) that persisted
until birth (n=3/3 trigenics). Additionally, although the trigenic OFT
was divided and separate aorta and pulmonary arteries exit their
respective right and left ventricles, there was a signiﬁcantly dilated
outﬂow lumen and possibly reduced endocardial cushion cells
(Fig. 8B). Further examination of the dorsal root ganglia, thymus
and craniofacial regions did not reveal any other histological defects
(not shown). Wnt1-Cre;R26r lineage mapping revealed that regular
numbers of NCC colonize the trigenic OFT and aorticopulmonary
septum at the appropriate developmental stage, and that they survive
until at least E13.5 (Fig. 8F) following post-migratory Smad7
overexpression. Additionally, histology revealed that the OFT was
fully divided and that the trigenic valves were normal (Fig. 8F).
Signiﬁcantly, myocardialization of the cushions occurs (Figs. 8G,H)
and there are similar levels of apoptosis (Figs. 8I,J) in both trigenic and
wildtype littermates. This is signiﬁcant as it has been proposed that
the relatively small population of cardiac NCC cells that migrate into
the proximal cushions are required to die to promote myocardializa-
tion (Poelmann et al., 2000).ap both the trigenic and control NCC populations, R26r lacZ reporter mice were crossed
iofacial and OFT regions. (A-C) E10 wholemount lacZ staining of trigenic and control
c (right embryo in A) cranial, cardiac and trunk regions when compared to control
l nerve ganglia, hypoplastic 1st, 2nd and 3rd arches and within the facial nerve ganglia,
the cardiac 4/6th arch region and the DRGs (*) in trigenic mutants. (D-J) LacZ stained
G,H) hearts viewed frontally (E,G) and from the right (F,H); and higher power views of
ann cells within SNS of trigenic forelimb (* in D), but trunk NCCmigration is unaltered.
he pharyngeal arches and aortic sac region, that a few mutant NCC can enter the OFT
in H) when compared to controls (E,F). Similarly, although trigenic NCC do colonize the
evident within the frontal nasal process and 3rd, 4th and 6th pharyngeal arches (arrow
nic embryos (L, L′, L″). Histology conﬁrms a lack of trigenic NCC colonizing the OFT, that
pic locations within the adjacent myocardial cuff (arrow in L′) or overlying endothelium.
hearts viewed frontally. Note the absent lacZ NCC within the trigenic upper and lower
(arrow in P). Abbreviations: ﬂ, forelimb; lv, left ventricle; a, atria; oft, outﬂow tract; ec,
Fig. 5. Elevated cell death of NCC in Smad7 trigenic mutants fed doxycycline at E7.5. (A-C) Ki67 staining at E10.5 on sagittal sections reveals equivalent levels of cell proliferation (n=4) within the trigenic 1st (B) and 2nd (not shown)
pharyngeal arches when compared to controls (A). (D-F) In contrast, TUNEL staining at E10.5 (n=4) demonstrates a notable increase in cell death in trigenic mutants within themandibular component of the 1st arch (arrow in E) compared to
controls (D). (G) TUNEL staining (brown) of lacZ-stained E11 R26r trigenic embryo (transverse section of right pharyngeal/OFT region lying on left hand side), demonstrates that apoptotic cells (arrows) are of NCC (blue) origin. Note that
trigenic non-NCC-derived core arch mesenchyme (indicated by yellow line), cephalic mesenchyme (cm) and body wall (bw) are largely devoid of apoptotic cells. However, as expected the pharyngeal pouch endoderm exhibits robust
apoptosis (*). (H-K) α-SMA staining showed that NCC differentiation into smooth muscle within the E10.5 trigenic (I) aortic sac was comparable to controls (H), that α-SMA staining (brown) within the trigenic OFT cushions was reduced (*)
and that transient cardiomyocyte expression of α-SMA was unaffected in both control and trigenic mutant hearts. Similarly, NCC-derived smooth muscle colonization of the control (J) and trigenic (K) 6th aortic arch arteries (arrows) was
comparable at E13.5. Abbreviations: as, aortic sac; a, atria; h, heart; PTA, persistent truncus arteriosus.
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Fig. 6.NCC-restricted Smad7 over-expression results in decreased TGFβ and BMP signaling. (A-H) pSmad2 immunohistochemistry on E10.5 sagittal sections demonstrated that TGFβ
signaling is reduced in both craniofacial and cardiovascular tissues colonized by NCC within trigenic (B,D,F) embryos fed doxycycline at E7.5 when compared to control littermates
(A,C,E) but that pSmad2 expression is unaffected within control (G) and trigenic (H) ventricles. Note that pSmad2-positive cells (brown staining) are signiﬁcantly reducedwithin the
trigenic mesenchymal nasal process and the overlying epithelium (* in B), as well as within the 1st pharyngeal archmesenchyme and overlying epithelium (* in D). Similarly, there is
almost a complete absence of pSmad2-positive NCC around the trigenic aortic sac and within the truncal region of the OFT (F). (I-P) pSmad1/5/8 immunohistochemistry on E10.5
sagittal sections similarly demonstrated that Bmp signaling is attenuated in both craniofacial and cardiovascular tissues colonized by NCC within trigenic (J,L,N) embryos fed
doxycycline at E7.5, when compared to control littermates (I,K,M) but that pSmad2 expression (brown staining) is unaffected within control (O) and trigenic (P) ventricles to which
NCC do not contribute. Sections were counterstained with 0.05% toluidine blue. Abbreviations: mes, mesenchyme of 1st arch; as, aortic sac. Bars in B,G,J,O=10 μm.
243S. Tang et al. / Developmental Biology 344 (2010) 233–247Despite being the foremost CHD found in patients, isolated VSD in
micemutants are usually found in associationwith alteredmyocardial
growth, OFT/AAA abnormalities and/or valvular defects (Conway et
al., 2003). VSD pathogenesis is complex and multifactorial and may
include underlying defects within the NCC, cardiomyocyte, endothe-
lial, endocardial cushion, epicardial and/or cardiac ﬁbroblast lineages;
that can each alter left-right ventricular morphogenesis, chamber
formation and septal positioning. Thus, the ability to induce isolated
VSDs will provide a useful mouse model in which to begin to address
the role of the NCC lineage in these CHDs.
Discussion
The physiological consequences of postnatal Smad7 dysregulation
is demonstrated by the ﬁnding that SMAD7 is upregulated in a
number of pathological conditions in patients; including development
of malignancy (Boulay et al., 2003; Arnold et al., 2004), scleroderma
(Asano et al., 2004), and chronic inﬂammatory bowel diseases
(Monteleone et al., 2001). Smad7 has also recently been shown tobe required for embryogenesis, as the majority of Smad7 knockout
mouse embryos die in utero due to multiple defects in cardiovascular
development, including VSD and OFT malformations (Chen et al.,
2009). Indeed, endogenous Smad7 mRNA is transiently activated
preimplantation, then is re-expressed widely post-gastrulation
(Zwijsen et al., 2000). In E10 and E12.5 embryos, Smad7 mRNA is
widespread outside the developing central nervous system; including
the NCC-derived mandibular and medial nasal processes, developing
pharyngeal arches, OFT cushions of the heart, adrenal primordium
and trigeminal ganglion (Zwijsen et al., 2000; Luukko et al., 2001).
Transgenic reporter and Cre/loxP lineage mapping using a partial
Smad7 promoter have also conﬁrmed the robust expression of Smad7
mRNA within the craniofacial, pharyngeal arch and cardiovascular
system (Liu et al., 2007; Snider et al., 2009). However, the role of
Smad7 within the NCC lineage and speciﬁcally the effects of mis-
regulation of Smad7 and overexpression in utero remain unknown.
We hypothesized that in vivo misexpression of a potent TGFβ
signaling inhibitor like Smad7, would generate severe NCC cell
hypoplasia and resultant neurocrestopathies. Our data provide
Fig. 7.Molecular marker analysis of E10.5 trigenic mutant phenotype. Radioactive in situ hybridization detection of Crabp1 (A,B), Ap2α (C,D) and Fgf8 (E,F) mRNA in control (A,C,E)
and trigenic mutants (B,D,F) fed doxycycline at E7.5. (A,B) Transverse sections through the OFT region of trigenic mutants reveal that Crabp1 expression is reduced within the
pharyngeal arch region around the foregut (indicated by * in B) and along the NCC migration routes around the dorsal aorta, but not within the thoracic body wall (arrows). (C,D)
Sagittal sections of trigenic mutants indicate that Ap2α expression is reduced in the trigenic nasal process (* in D) and that Ap2α is ectopically expressed within the mesenchyme of
1st arch (arrow) when compared to control littermate (C). (E,F) Sagittal sections of trigenic mutants also reveal that Fgf8 expression is upregulated within the epithelium overlying
the nasal process (* in F) and 1st arch mesenchyme (arrow in F) but that trigenic Fgf8 expression within the neural epithelial layer of the optic cup is comparable with control
expression levels. Abbreviations: da, dorsal aorta; oft, outﬂow tract; e, eye.
244 S. Tang et al. / Developmental Biology 344 (2010) 233–247compelling genetic evidence demonstrating that forced expression of
Smad7 within NCC is detrimental to the NCC subpopulations that
colonize the OFT and craniofacial regions. Moreover, we showed that
levels of both TGFβ and BMP phosphorylated R-Smads were reduced
in the NCC expressing myc-Smad7. Since TGFβ superfamily signaling
is known to increase production of phosphorylated forms of R-Smad
proteins, our data provide good evidence that TGFβ signaling in vivo is
impaired by myc-Smad7 induction in NCC. The spectrum of trigenic
phenotypes ﬁt well with previous studies reporting craniofacial,
pharyngeal, cardiac defects and in utero lethality within NCC-
restricted Wnt1-Cre;Smad4loxp/loxp embryo mutants (Ko et al., 2007;
Jia et al., 2007; Nie et al., 2008; Büchmann-Møller et al., 2009). Thus,
combined these data strongly suggest that altered NCC TGFβ
superfamily signaling, either via targeted deletion of Smad4 or
upregulation of Smad7 can both play pathogenic roles that result in
neurocrestopathies. Although we observed an OFT defect and VSD in
the trigenic embryos fed doxycycline from E7.5 onwards, it may not
be the primary cause of the mid-gestation lethality, because an OFT
defect or PTA is not necessarily lethal until birth (Conway et al., 1997;
Conway et al., 2003). Further experiments are required to determine
the primary cause of embryonic lethality of the myc-Smad7 trigenic
embryos.
Although members of the Wnt family have been shown to specify
NCC from early dorsal neuroepithelial cells (Dorsky et al., 2000;
García-Castro et al., 2002) and Wnt/β-Catenin signal activation plays
an instructive role in the speciﬁcation of NCC sensory fate (Lee et al.,
2004); the molecular mechanisms underlying the determination,
pathway-dependent control and morphogenesis of the diversity of
NCC fates remain far from clear. Some alternative NCC fates have been
shown to be instructively promoted by TGFβ superfamily members
(Shah et al., 1996: Dorsky et al., 2000). For example, Bmp2 causes
cloned NCC to form autonomic neurons and can also induce some
smooth muscle differentiation, whilst TGFβ1 exclusively promotes
smooth muscle differentiation (Shah et al., 1996). Surprisingly,
although our lineage analysis and immunohistochemical assays
revealed robust NCC death within trigenic embryos fed doxycycline
from E7.5 onwards, subsequent NCC colonization of the trigenic dorsal
root ganglia, trigeminal ganglion, thymus and αSMA-positive NCC-derived subpopulation that ensheath the remodeling trigenic AAA
which give rise to the great vessels exiting the heart were all
unaffected (Figs. 4, 5). Thus, Smad7 induction appears to aberrantly
affect speciﬁc subpopulations of NCC, independent of where they
originate from, when they initiate migration or even how far they are
required to migrate prior to target tissue colonization. Indeed, forced
expression of Smad7 within pancreatic beta cells (Smart et al., 2006)
and human umbilical cord blood cells (Chadwick et al., 2005) has
similarly been shown to inhibit differentiated cell formation and
suppression of TGFβ signaling alters cell fate decisions.
Craniofacial and cardiac defects thought to arise principally from
perturbation of NCC morphogenesis are prominent features of
DiGeorge syndrome (DGS)/velocardiofacial syndrome (VCFS), as
well as Noonan syndrome (NS) (Moon et al., 2006; Nakamura et al.,
2009). While NS is caused by a gain-of-function mutation in SHP2
(Nakamura et al., 2009) and Wnt1-Cre lineage restricted deletion of
Shp2 (Nakamura et al., 2009) and subsequent Erk1/2 activation
(Newbern et al., 2008) both result in a similar spectrum of cardiac and
craniofacial defects as seen in the trigenics, DGS/VCFS is the result of a
recurrent deletion in chromosome 22q11 (Kobrynski and Sullivan,
2007). DGS/VCFS is the most common micro-deletion syndrome in
patients (Moon et al., 2006), but not all DGS/VCFS patients have the
22q11 deletion (Shaikh et al., 2007; Rope et al., 2009). Additionally,
several modiﬁers of the DGS/VCFS have been identiﬁed in patients
and modeled using mouse transgenics; including VEGF (Stalmans et
al., 2003), FGF8 (Moon et al., 2006) and CHD7 (Randall et al., 2009).
Although the microdeletion of 22q11 encompasses ∼30 genes, it does
not include any of the TGFβ superfamily receptors or ligands. Thus,
gene products eliminated by 22q11 deletions may functionally
interact with TGFβ signaling within the NCC lineage. For instance,
MED15 has been shown to modulate TGFβ signaling within embryos
(Kato et al., 2002), and both Tbx1 (Randall et al., 2009) and Crkl
(Wurdak et al., 2005) can directly regulate TGFβ signaling within
murine NCC via modulating R-Smad phosphorylation and altering the
ability of R-Smads to bind Smad4 (Fulcoli et al., 2009). Furthermore,
loss of Crkl disrupts Erk1/2 activation (Moon et al., 2006). These
ﬁndings imply that the common developmental abnormalities
observed in DGS/VCFS and NS patients may arise from perturbation
245S. Tang et al. / Developmental Biology 344 (2010) 233–247of the same pathway. Although the reduced expression levels of Ap2α
and Crabp1 mRNA are to be expected (Fig. 7) given the observed
elevation of NCC death (Fig. 5), our molecular marker analysis did
reveal an unexpected ﬁnding. One particularly signiﬁcant discovery is
that Fgf8 levels are elevated within the epithelia of the trigenic
pharyngeal arches, as FGF8 is a knownmodiﬁer of DGS/VCFS and Fgf8
signaling is mediated by Crkl (Moon et al., 2006). Functions of these
genes have been implicated in mediating interactions between NCCand their neighboring cells in facial primordia and pharyngeal arches,
and subsequent organogenesis (Noden and Trainor, 2005). Combined,
these data indicate that suppression of TGFβ signaling within the
cranial and cardiac NCC disrupts not only distinct NCC gene
expression, but also normal developmental processes in neighboring
cell populations. In order to ﬁnd the common downstream effectors,
detailed analysis of the resultant gene expression proﬁle changes
within isolated trigenic NCC subpopulations will be required to
identify which NCC-restricted gene pathways are altered in response
to suppressed TGFβ signaling.
The spectrum of cardiac defects caused by Smad7 induction in
early NCC resembles those associated with cardiac NCC ablation in
avian embryos, in which both anomalous AAA remodeling and lack of
OFT septation with concomitant VSDs are observed (Hutson and
Kirby, 2007). Cardiac NCC normally migrate to the OFT region via the
3rd, 4th and 6th pharyngeal arches to form the two-pronged cushions
in the truncal region of the OFTwhere they contribute to the septation
of aorta and pulmonary outlets (Gittenberger-de Groot et al., 2005).
However, not all cardiac NCC colonize the OFT cushions, as a
subpopulation remains in the caudal pharyngeal arches and differ-
entiates in a smooth muscle layer enveloping the 4th and 6th arch
arteries (Kirby et al., 1997; Jiang et al., 2000). Surprisingly, despite
extensive NCC death and reducedWnt1-Cre;R26r reporter expression
within trigenic mutants that exhibit severe OFT septation and VSD
defects, the AAAs have smooth muscle tunics (Figs. 4, 5). This is
consistent with the phenotypes reported in Wnt1-Cre;Smad4loxp/loxp
and Wnt1-Cre;Tgfbr2loxp/loxp mutants (Ko et al., 2007; Jia et al., 2007;
Nie et al., 2008; Büchmann-Møller et al., 2009; Choudhary et al.,
2006), Thus, OFT septation defects appear to be a common feature of
all mouse models in which TGFβ signaling is impaired in NCC,
indicating a central role for TGFβ superfamily signaling within NCC
during cardiac development. Although it is possible for embryos to
exhibit OFT septation defects without AAA abnormalities and it is
possible to have AAA defects without OFT septation defects (Kirby et
al., 1997), it remains unclear why suppression of TGFβ signaling
within the cardiac NCC subpopulation predominantly results in only
OFT septation and VSD defects. It has been proposed that TGFβ
signaling may not be required for speciﬁcation of a smooth muscle
fate, that this is a default pathway or that TGFβ signaling within
cardiac NCC acts as a local morphogenic factor rather than as an
instructural cue for cell lineage speciﬁcation or smooth muscle
differentiation (Choudhary et al., 2006). Our trigenic data would
support these conclusions and additionally infer that TGFβ signaling
in cardiac NCC within pharyngeal arches is required to provide the
stimulus for subsequent NCC colonization of the OFT itself, septation
and for survival of this colonizing OFT subpopulation. This conclusion
is further supported by our signiﬁcant ﬁnding that later induction of
Smad7 in NCC that have already reached the pharyngeal arches and
OFT also results in VSD (Fig. 8). Since Smad7 blocks multiple receptor-
activated TGFβ signaling pathways, our work has not yet revealedFig. 8. Analysis of E14.5 Smad7 trigenic heart phenotypes fed doxycycline at E10. (A,B)
Control and trigenic littermate OFT regions sectioned transversely and stained with
H&E. Note both the control (A) and trigenic (B) left and right lobes of the thymic
rudiment are normally situated and unaffected bymyc-Smad7 induction (n=4 trigenic
and 5 control fetuses). However, the trigenic OFT truncal endocardial cushions are
smaller and the lumen of the outlet of the right ventricle is abnormally dilated (arrow in
B). (C,D) Additionally, the trigenic embryo exhibits an isolated VSD (arrow in D) but the
control heart is septated normally (C). (E,F) To lineage map both the trigenic and
control post-migratory NCC populations, R26r lacZ reporter mice were crossed with
Smad7 trigenic mice. Transverse sections through the E13.5 OFT revealed similar
patterns of cardiac NCC (blue) within the aorticopulmonary septum (not shown) and
valves in both control (E) and trigenic (F) littermates. Note that trigenic cardiac NCC are
still present and that the valves are normal. (G,H) α-SMA staining showed that
myocardialization occurs normally in both E13.5 control (G) and trigenic (H) hearts.
Note active myocardialization of endocardial cushions at base of the OFTs (indicated
by *). (I,J) TUNEL staining (brown) revealed that both the patterns and level of
apoptosis (indicated by arrows) are grossly similar in E13.5 control (I) and trigenic (J)
OFTs. Abbreviations: thy, thymic lobes; rv, right ventricle.
246 S. Tang et al. / Developmental Biology 344 (2010) 233–247roles of individual receptor-mediated TGFβ pathways that are
responsible for maintaining these colonizing OFT NCC subpopulation.
Elucidating the molecular pathways and mechanisms regulating
the fate of the cranial and cardiac NCC subpopulations is fundamental
to our understanding of the pathogenesis of numerous congenital
syndromes. In addition to stimulatory factors, migrating NCC
encounter environments rich in inhibitors that may counteract the
inﬂuences of signaling molecules such as Wnts, BMPs and TGFβ. Our
Smad7 inhibitory NCC-restricted studies reinforce the notion that
TGFβ signaling is dispensable for NCC formation and emigration but
plays a critical role during craniofacial and cardiac NCC morphogen-
esis and colonization of target tissues.We observed a severe reduction
of NCC pSmad2 and pSmad1/5/8 expression, resulting in suppression
of the temporal and spatial speciﬁcation of TGFβ signaling and
subsequent loss of craniofacial and OFT cushion NCC in trigenic Smad7
embryos. Moreover, Smad7 overexpression within post-migratory
cardiac NCC also resulted in cardiac defects, suggested that TGFβ
signaling plays multiple roles at multiple times, even in the same NCC
subpopulation. Although there is a paucity of data regarding the
function of post-migratory NCC within the heart itself, it has been
shown that NCC-speciﬁc N-cadherin, RhoA and Cx43 expression are
each required for normal OFT morphogenesis, cell shape, alignment
and cell-cell communication. Wnt1-Cre;N-cadherin mutant NCC are
unable to elongate and align properly along the midline and remained
rounded with limited contact with their neighbors within mutant
OFTs (Luo et al., 2006). Activation of RhoA is required for NCC contact
inhibition of locomotion in vivo to control NCC directional migration
(Carmona-Fontaine et al., 2008); whilst Cx43 mediates modulation of
polarized cell movement and the directional migration of cardiac NCC
(Xu et al., 2006). Signiﬁcantly, N-cadherin, RhoA and Cx43 are all
known to be responsive to TGFβ-signaling (Massagué, 2008;
Asazuma-Nakamura et al., 2009), thus these data suggest that further
studies are required to understand the link between lineage
commitment and the many changes in cushion cell shape, cell-matrix
adhesion, and cell-cell adhesion that occur within the OFT itself and
during interventricular septal morphogenesis, and how suppression
of TGFβ superfamily signaling may aberrantly affect one or more of
these processes. Perhaps inhibitors of TGFβ inhibitors are required to
titrate or delay responses as NCC differentiate along particular
pathways, and that Smad7 overexpression prevents endocardial
cushion differentiation resulting in defective septation. Taken togeth-
er, these results demonstrate that ﬁne-tuning of TGFβ signaling via
proteins including Smad7 is crucial for normal development. We
speculate that this method for conditional myc-Smad7 expression
may be useful for elucidating further TGFβ roles in other organs and
tissues and addressing the biological signiﬁcance of the concerted
action between growth and transcription factors in regulating normal
development and disease.
Acknowledgments
We thank Mica Gosnell, Goldie Lin and Jian Wang for histological,
immunohistochemical and in situ hybridization support. We are also
grateful to Dr. Andras Nagy (Samuel Lunenfeld Research Institute) for
providing the pUHD10-3 vector; Dr. Yan Chen (Chinese Academy of
Science) for the Smad7 cDNA vector and Dr. Henry Sucov (University
of Southern California) for providing Wnt1-Cre mice. These studies
were supported, in part, by NIH HL60714/HL92508 (SJC), HL85098
(AF and SJC), AHA Pre-Doc Fellowship (ST), Riley Children's
Foundation and IU Department of Pediatrics/Cardiology support
(SJC).
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ydbio.2010.05.004.References
Anderson, R.M., Stottmann, R.W., Choi, M., Klingensmith, J., 2006. Endogenous bone
morphogenetic protein antagonists regulate mammalian neural crest generation
and survival. Dev. Dyn. 235 (9), 2507–2520.
Arnold, N.B., Ketterer, K., Kleeff, J., Friess, H., Büchler, M.W., Korc, M., 2004. Thioredoxin
is downstream of Smad7 in a pathway that promotes growth and suppresses
cisplatin-induced apoptosis in pancreatic cancer. Cancer Res. 64 (10), 3599–3606.
Asano, Y., Ihn, H., Yamane, K., Kubo, M., Tamaki, K., 2004. Impaired Smad7-Smurf-
mediated negative regulation of TGF-beta signaling in scleroderma ﬁbroblasts. J.
Clin. Invest. 113 (2), 253–264.
Asazuma-Nakamura, Y., Dai, P., Harada, Y., Jiang, Y., Hamaoka, K., Takamatsu, T., 2009.
Cx43 contributes to TGF-beta signaling to regulate differentiation of cardiac
ﬁbroblasts into myoﬁbroblasts. Exp. Cell Res. 315, 1190–1199.
Aybar, M.J., Mayor, R., 2002. Early induction of neural crest cells: lessons learned from
frog, ﬁsh and chick. Curr. Opin. Genet. Dev. 12 (4), 452–458.
Belteki, G., Haigh, J., Kabacs, N., Haigh, K., Sison, K., Costantini, F., Whitsett, J., Quaggin, S.
E., Nagy, A., 2005. Conditional and inducible transgene expression in mice through
the combinatorial use of Cre-mediated recombination and tetracycline induction.
Nucleic Acids Res. 33 (5), e51.
Boulay, J.L., Mild, G., Lowy, A., Reuter, J., Lagrange, M., Terracciano, L., Laffer, U.,
Herrmann, R., Rochlitz, C., 2003. SMAD7 is a prognostic marker in patients with
colorectal cancer. Int. J. Cancer 104 (4), 446–449.
Brault, V., Moore, R., Kutsch, S., Ishibashi, M., Rowitch, D.H., McMahon, A.P., Sommer, L.,
Boussadia, O., Kemler, R., 2001. Inactivation of the beta-catenin gene by Wnt1-Cre-
mediated deletion results in dramatic brain malformation and failure of
craniofacial development. Development 128 (8), 1253–1264.
Brewer, S., Jiang, X., Donaldson, S., Williams, T., Sucov, H.M., 2002. Requirement for AP-
2alpha in cardiac outﬂow tract morphogenesis. Mech. Dev. 110, 139–149.
Büchmann-Møller, S., Miescher, I., John, N., Krishnan, J., Deng, C.X., Sommer, L., 2009.
Multiple lineage-speciﬁc roles of Smad4 during neural crest development. Dev.
Biol. 330 (2), 329–338.
Casellas, R., Brivanlou, A.H., 1998. Xenopus Smad7 inhibits both the activin and BMP
pathways and acts as a neural inducer. Dev. Biol. 198, 1–12.
Carmona-Fontaine, C., Matthews, H.K., Kuriyama, S., Moreno, M., Dunn, G.A., Parsons,
M., Stern, C.D., Mayor, R., 2008. Contact inhibition of locomotion in vivo controls
neural crest directional migration. Nature 456 (7224), 957–961.
Chadwick, K., Shojaei, F., Gallacher, L., Bhatia, M., 2005. Smad7 alters cell fate decisions
of human hematopoietic repopulating cells. Blood 105 (5), 1905–1915.
Chai, Y., Jiang, X., Ito, Y., Bringas, P., Han, J., Rowitch, D.H., Soriano, P., McMahon, A.P.,
Sucov, H.M., 2000. Fate of the mammalian cranial neural crest during tooth and
mandibular morphogenesis. Development 127, 1671–1679.
Chen, Q., Chen, H., Zheng, D., Kuang, C., Fang, H., Zou, B., Zhu, W., Bu, G., Jin, T., Wang, Z.,
Zhang, X., Chen, J., Field, L.J., Rubart, M., Shou, W., Chen, Y., 2009. Smad7 is required
for the development and function of the heart. J. Biol. Chem. 284 (1), 292–300.
Choudhary, B., Ito, Y., Makita, T., Sasaki, T., Chai, Y., Sucov, H.M., 2006. Cardiovascular
malformations with normal smooth muscle differentiation in neural crest-speciﬁc
type II TGFbeta receptor (Tgfbr2) mutant mice. Dev. Biol. 289, 420–429.
Conway, S.J., Henderson, D.J., Copp, A.J., 1997. Pax3 is required for cardiac neural crest
migration in the mouse: evidence from the (Sp2H) mutant. Development 124,
505–514.
Conway, S.J., Bundy, J., Chen, J., Dickman, E., Rogers, R., Will, B.M., 2000. Abnormal
neural crest stem cell expansion is responsible for the conotruncal heart defects
within the Splotch (Sp2H) mouse mutant. Cardiovasc. Res. 47, 314–328.
Conway, S.J., Kruzynska-Frejtag, A., Kneer, P.L., Machnicki, M., Koushik, S.V., 2003. What
cardiovascular defect does my prenatal mouse mutant have, and why? Genesis 35
(1), 1–21.
Dietrich, P., Shanmugasundaram, R., Shuyu, E., Dragatsis, I., 2009. Congenital
hydrocephalus associated with abnormal subcommissural organ in mice lacking
huntingtin in Wnt1 cell lineages. Hum. Mol. Genet. 18 (1), 142–150.
Dorsky, R.I., Moon, R.T., Raible, D.W., 2000. Environmental signals and cell fate
speciﬁcation in premigratory neural crest. Bioessays 22 (8), 708–716.
Dudas, M., Sridurongrit, S., Nagy, A., Okazaki, K., Kaartinen, V., 2004. Craniofacial defects
in mice lacking BMP type I receptor Alk2 in neural crest cells. Mech. Dev. 121,
173–182.
Epstein, J.A., Li, J., Lang, D., Chen, F., Brown, C.B., Jin, F., Lu, M.M., Thomas, M., Liu, E.,
Wessels, A., Lo, C.W., 2000. Migration of cardiac neural crest cells in Splotch
embryos. Development 127 (9), 1869–1878.
Frank, D.U., Fotheringham, L.K., Brewer, J.A., Muglia, L.J., Tristani-Firouzi, M., Capecchi,
M.R., Moon, A.M., 2002. An Fgf8 mouse mutant phenocopies human 22q11 deletion
syndrome. Development 129, 4591–4603.
Fulcoli, F.G., Huynh, T., Scambler, P.J., Baldini, A., 2009. Tbx1 regulates the BMP-Smad1
pathway in a transcription independent manner. PLoS One 4 (6), e6049.
García-Castro, M.I., Marcelle, C., Bronner-Fraser, M., 2002. EctodermalWnt function as a
neural crest inducer. Science 297 (5582), 848–851.
Gittenberger-de Groot, A.C., Bartelings, M.M., Deruiter, M.C., Poelmann, R.E., 2005.
Basics of cardiac development for the understanding of congenital heart
malformations. Pediatr. Res. 57, 169–176.
Han, G., Li, A.G., Liang, Y.Y., Owens, P., He, W., Lu, S., Yoshimatsu, Y., Wang, D., Ten Dijke,
P., Lin, X., Wang, X.J., 2006. Smad7-induced beta-catenin degradation alters
epidermal appendage development. Dev. Cell 11 (3), 301–312.
Han, J., Ishii, M., Bringas Jr., P., Maas, R.L., Maxson Jr., R.E., Chai, Y., 2007. Concerted
action of Msx1 and Msx2 in regulating cranial neural crest cell differentiation
during frontal bone development. Mech. Dev. 124 (9–10), 729–745.
Hayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y.Y., Grinnell, B.W., Richardson, M.A., Topper,
J.N., Gimbrone Jr., M.A., Wrana, J.L., Falb, D., 1997. The MAD-related protein Smad7
247S. Tang et al. / Developmental Biology 344 (2010) 233–247associates with the TGFbeta receptor and functions as an antagonist of TGFbeta
signaling. Cell 89, 1165–1173.
Helms, J.A., Cordero, D., Tapadia, M.D., 2005. New insights into craniofacial
morphogenesis. Development 132, 851–861.
Hutson, M.R., Kirby, M.L., 2007. Model systems for the study of heart development and
disease. Cardiac neural crest and conotruncal malformations. Semin. Cell Dev. Biol.
18 (1), 101–110.
Ishisaki, A., Yamato, K., Hashimoto, S., Nakao, A., Tamaki, K., Nonaka, K., ten Dijke, P.,
Sugino, H., Nishihara, T., 1999. Differential inhibition of Smad6 and Smad7 on bone
morphogenetic protein- and activin-mediated growth arrest and apoptosis in B
cells. J. Biol. Chem. 274, 13637–13642.
Ito, Y., Yeo, J.Y., Chytil, A., Han, J., Bringas Jr., P., Nakajima, A., Shuler, C.F., Moses, H.L.,
Chai, Y., 2003. Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft
palate and calvaria defects. Development 130, 5269–5280.
Itoh, S., ten Dijke, P., 2007. Negative regulation of TGF-β receptor/Smad signal
transduction. Curr. Opin. Cell Biol. 19, 176–184.
Jia, Q., McDill, B.W., Li, S.Z., Deng, C., Chang, C.P., Chen, F., 2007. Smad signaling in the
neural crest regulates cardiac outﬂow tract remodeling through cell autonomous
and non-cell autonomous effects. Dev. Biol. 311, 172–184.
Jiang, X., Rowitch, D.H., Soriano, P., McMahon, A.P., Sucov, H.M., 2000. Fate of the
mammalian cardiac neural crest. Development 127, 1607–1616.
Kaartinen, V., Dudas, M., Nagy, A., Sridurongrit, S., Lu, M.M., Epstein, J.A., 2004. Cardiac
outﬂow tract defects in mice lacking ALK2 in neural crest cells. Development 131,
3481–3490.
Kanzler, B., Foreman, R.K., Labosky, P.A., Mallo, M., 2000. BMP signaling is essential for
development of skeletogenic and neurogenic cranial neural crest. Development
127, 1095–1104.
Kato, Y.,Habas, R.,Katsuyama,Y.,Näär, A.M.,He,X., 2002.A componentof theARC/Mediator
complex required for TGF beta/Nodal signalling. Nature. 418 (6898), 641–646.
Kirby, M.L., Waldo, K.L., 1995. Neural crest and cardiovascular patterning. Circ. Res. 77,
211–215.
Kirby, M.L., Hunt, P., Wallis, K., Thorogood, P., 1997. Abnormal patterning of the aortic
arch arteries does not evoke cardiac malformations. Dev. Dyn. 208 (1), 34–47.
Knecht, A.K., Bronner-Fraser, M., 2002. Induction of the neural crest: a multigene
process. Nat. Rev. Genet. 3 (6), 453–461.
Ko, S.O., Chung, I.H., Xu, X., Oka, S., Zhao, H., Cho, E.S., Deng, C., Chai, Y., 2007. Smad4 is
required to regulate the fate of cranial neural crest cells. Dev. Biol. 312 (1), 435–447.
Kobrynski, L.J., Sullivan, K.E., 2007. Velocardiofacial syndrome, DiGeorge syndrome: the
chromosome 22q11.2 deletion syndromes. Lancet 370 (9596), 1443–1452.
Kuang, C., Xiao, Y., Liu, X., Stringﬁeld, T.M., Zhang, S., Wang, Z., Chen, Y., 2006. In vivo
disruption of TGF-beta signaling by Smad7 leads to premalignant ductal lesions in
the pancreas. PNAS U.S.A. 103, 1858–1863.
Kwang, S.J., Brugger, S.M., Lazik, A., Merrill, A.E., Wu, L.Y., Liu, Y.H., Ishii, M., Sangiorgi, F.
O., Rauchman, M., Sucov, H.M., Maas, R.L., Maxson Jr., R.E., 2002. Msx2 is an
immediate downstream effector of Pax3 in the development of the murine cardiac
neural crest. Development 129 (2), 527–538.
Le Douarin, N.M., Kalcheim, C., 1999. The Neural Crest. Cambridge University Press, New
York.
Lee, H.Y., Kléber, M., Hari, L., Brault, V., Suter, U., Taketo, M.M., Kemler, R., Sommer, L.,
2004. Instructive role of Wnt/beta-catenin in sensory fate speciﬁcation in neural
crest stem cells. Science 303 (5660), 1020–1023.
Liu, X., Chen, Q., Kuang, C., Zhang, M., Ruan, Y., Xu, Z.C., Wang, Z., Chen, Y., 2007. A 4.3 kb
Smad7 promoter is able to specify gene expression during mouse development.
Biochim. Biophys. Acta 1769, 149–152.
Luo, Y., High, F.A., Epstein, J.A., Radice, G.L., 2006. N-cadherin is required for neural crest
remodeling of the cardiac outﬂow tract. Dev. Biol. 299 (2), 517–528.
Luukko, K., Ylikorkala, A., Mäkelä, T.P., 2001. Developmentally regulated expression of
Smad3, Smad4, Smad6, and Smad7 involved in TGF-beta signaling. Mech. Dev. 101
(1–2), 209–212.
Massagué, J., Seoane, J., Wotton, D., 2005. Smad transcription factors. Genes Dev. 19,
2783–2810.
Massagué, J., 2008. TGFbeta in Cancer. Cell 134 (2), 215–230.
Monteleone, G., Kumberova, A., Croft, N.M., McKenzie, C., Steer, H.W., MacDonald, T.T.,
2001. Blocking Smad7 restores TGF-beta1 signaling in chronic inﬂammatory bowel
disease. J. Clin. Invest. 108 (4), 601–609.
Morikawa, Y., Zehir, A., Maska, E., Deng, C., Schneider,M.D.,Mishina, Y., Cserjesi, P., 2009.
BMP signaling regulates sympathetic nervous systemdevelopment through Smad4-
dependent and -independent pathways. Development 136 (21), 3575–3584.
Moon, A.M., Guris, D.L., Seo, J.H., Li, L., Hammond, J., Talbot, A., Imamoto, A., 2006. Crkl
deﬁciency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes.
Dev. Cell 10 (1), 71–80.
Moustakas, A., Heldin, C.H., 2009. The regulation of TGFbeta signal transduction.
Development 136 (22), 3699–3714.
Nakamura, T., Gulick, J., Pratt, R., Robbins, J., 2009. Noonan syndrome is associated with
enhanced pERK activity, the repression of which can prevent craniofacial
malformations. PNAS U.S.A. 106 (36), 15436–15441.
Nakao, A., Afrakhte, M., Moren, A., Nakayama, T., Christian, J.L., Heuchel, R., Itoh, S.,
Kawabata, M., Heldin, N.E., Heldin, C.H., ten Dijke, P., 1997. Identiﬁcation of Smad7,
a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389, 631–635.
Newbern, J., Zhong, J., Wickramasinghe, R.S., Li, X., Wu, Y., Samuels, I., Cherosky, N.,
Karlo, J.C., O'Loughlin, B., Wikenheiser, J., Gargesha, M., Doughman, Y.Q., Charron, J.,
Ginty, D.D., Watanabe, M., Saitta, S.C., Snider, W.D., Landreth, G.E., 2008. Mouse and
human phenotypes indicate a critical conserved role for ERK2 signaling in neural
crest development. PNAS U.S.A. 105 (44), 17115–17120.
Nichols, D.H., 1981. Neural crest formation in the head of themouse embryo as observed
using a new histological technique. J. Embryol. Exp. Morphol. 64, 105–120.Nie, X., Deng, C.X., Wang, Q., Jiao, K., 2008. Disruption of Smad4 in neural crest cells
leads to mid-gestation death with pharyngeal arch, craniofacial and cardiac defects.
Dev. Biol. 316, 417–430.
Noden, D.M., Trainor, P.A., 2005. Relations and interactions between cranial mesoderm
and neural crest populations. J. Anat. 207, 575–601.
Osumi-Yamashita, N., Ninomiya, Y., Doi, H., Eto, K., 1994. The contribution of both
forebrain and midbrain crest cells to the mesenchyme in the frontonasal mass of
mouse embryos. Dev. Biol. 164, 409–419.
Perl, A.K., Tichelaar, J.W., Whitsett, J.A., 2002. Conditional gene expression in the
respiratory epithelium of the mouse. Transgenic Res. 11 (1), 21–29.
Poelmann, R.E., Molin, D., Wisse, L.J., Gittenberger-de Groot, A.C., 2000. Apoptosis in
cardiac development. Cell Tissue Res. 301 (1), 43–52.
Randall, V., McCue, K., Roberts, C., Kyriakopoulou, V., Beddow, S., Barrett, A.N., Vitelli, F.,
Prescott, K., Shaw-Smith, C., Devriendt, K., Bosman, E., Steffes, G., Steel, K.P., Simrick,
S., Basson, M.A., Illingworth, E., Scambler, P.J., 2009. Great vessel development
requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in mice. J.
Clin. Invest. 119 (11), 3301–3310.
Rios, H., Koushik, S.V., Wang, H., Wang, J., Zhou, H.M., Lindsley, A., Rogers, R., Chen, Z.,
Maeda, M., Kruzynska-Frejtag, A., Feng, J.Q., Conway, S.J., 2005. Periostin null mice
exhibit dwarﬁsm, incisor enamel defects, and an early-onset periodontal disease-
like phenotype. Mol. Cell. Biol. 25 (24), 11131–11144.
Rope, A.F., Cragun, D.L., Saal, H.M., Hopkin, R.J., 2009. DiGeorge anomaly in the absence
of chromosome 22q11.2 deletion. J. Pediatr. 155 (4), 560–565.
Saika, S., Yamanaka, O., Nishikawa-Ishida, I., Kitano, A., Flanders, K.C., Okada, Y., Ohnishi,
Y., Nakajima, Y., Ikeda, K., 2007. Effect of Smad7 gene overexpression on
transforming growth factor beta-induced retinal pigment ﬁbrosis in a proliferative
vitreoretinopathy mouse model. Arch. Ophthal. 125, 647–654.
Serbedzija, G.N., Bronner-Fraser, M., Fraser, S.E., 1992. Vital dye analysis of cranial
neural crest cell migration in the mouse embryo. Development 116, 297–307.
Shah, N.M., Groves, A.K., Anderson, D.J., 1996. Alternative neural crest cell fates are
instructively promoted by TGFbeta superfamily members. Cell 85, 331–343.
Shaikh, T.H., O'Connor, R.J., Pierpont, M.E., McGrath, J., Hacker, A.M., Nimmakayalu, M.,
Geiger, E., Emanuel, B.S., Saitta, S.C., 2007. Low copy repeats mediate distal
chromosome 22q11.2 deletions: sequence analysis predicts breakpoint mechan-
isms. Genome Res. 17 (4), 482–491.
Smart, N.G., Apelqvist, A.A., Gu, X., Harmon, E.B., Topper, J.N., MacDonald, R.J., Kim, S.K.,
2006. Conditional expression of Smad7 in pancreatic beta cells disrupts TGF-beta
signaling and induces reversible (maybe future studies shown if only diabetes
mellitus. PLoS Biol. 4 (2), e39.
Snider, P., Conway, S.J., 2007. Developmental biology: the power of the blood. Nature
450, 180–181.
Snider, P., Olaopa, M., Firulli, A.B., Conway, S.J., 2007. Cardiovascular development and
the colonizing cardiac neural crest lineage. ScientiﬁcWorldJ. 7, 1090–1113.
Snider, P., Fix, J.L., Rogers, R., Peabody-Dowling, G., Ingram, D., Lilly, B., Conway, S.J.,
2008. Generation and characterization of Csrp1 enhancer-driven tissue-restricted
cre recombinase mice. Genesis 46, 167–176.
Snider, P., Tang, S., Lin, G., Wang, J., Conway, S.J., 2009. Generation of Smad7(-Cre)
recombinase mice: a useful tool for the study of epithelial-mesenchymal
transformation within the embryonic heart. Genesis 47 (7), 469–475.
Sonnenberg-Riethmacher, E.,Miehe,M., Stolt, C.C., Goerich,D.E.,Wegner,M., Riethmacher,
D., 2001. Development and degeneration of dorsal root ganglia in the absence of the
HMG-domain transcription factor Sox10. Mech. Dev. 109 (2), 253–265.
Soriano, P., 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat.
Genet. 21, 70–71.
Stalmans, I., Lambrechts, D., Desmet, F., Jansen, S., Wang, J., Maity, S., Kneer, P., von der
Ohe, M., Swillen, A., Maes, C., Molin, D., Hellings, P., Boetel, T., Haardt, M.,
Compernolle, V., Dewerchin, M., Emanuel, B., Gittenberger-de Groot, A., Esguerra,
C., Scambler, P., Morrow, B., Driscol, D., Moons, L., Carmeliet, G., Behn-Krappa, A.,
Devriendt, K., Collen, D., Conway, S.J., Carmeliet, P., 2003. VEGF: a modiﬁer of the
del22q11 (DiGeorge) syndrome? Nat. Med. 9, 173–182.
Stottmann, R.W., Choi, M., Mishina, Y., Meyers, E.N., Klingensmith, J., 2004. BMP
receptor IA is required in mammalian neural crest cells for development of the
cardiac outﬂow tract and ventricular myocardium. Development 131, 2205–2218.
Wang, Y.Q., Sizeland, A., Wang, X.F., Sassoon, D., 1995. Restricted expression of type-II
TGF beta receptor in murine embryonic development suggests a central role in
tissue modeling and CNS patterning. Mech. Dev. 52 (2–3), 275–289.
Wang, J., Nagy, A., Larsson, J., Dudas, M., Sucov, H.M., Kaartinen, V., 2006. Defective ALK5
signaling in the neural crest leads to increased postmigratory neural crest cell
apoptosis and severe outﬂow tract defects. BMC Dev. Biol. 6, 51.
Wurdak, H., Ittner, L.M., Lang, K.S., Leveen, P., Suter, U., Fischer, J.A., Karlsson, S., Born,
W., Sommer, L., 2005. Inactivation of TGFbeta signaling in neural crest stem
cells leads to multiple defects reminiscent of DiGeorge syndrome. Genes Dev. 19,
530–535.
Xu, X., Francis, R., Wei, C.J., Linask, K.L., Lo, C.W., 2006. Connexin 43-mediated
modulation of polarized cell movement and the directional migration of cardiac
neural crest cells. Development 133 (18), 3629–3639.
Zambrowicz, B.P., Imamoto, A., Fiering, S., Herzenberg, L.A., Kerr, W.G., Soriano, P., 1997.
Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads
to widespread expression of beta-galactosidase in mouse embryos and hemato-
poietic cells. PNAS U.S.A. 94 (8), 3789–3794.
Zhou, H.M., Wang, J., Rogers, R., Conway, S.J., 2008. Lineage-speciﬁc responses to
reduced embryonic Pax3 expression levels. Dev. Biol. 315 (2), 369–382.
Zwijsen, A., van Rooijen, M.A., Goumans, M.J., Dewulf, N., Bosman, E.A., ten Dijke, P.,
Mummery, C.L., Huylebroeck, D., 2000. Expression of the inhibitory Smad7 in early
mouse development and upregulation during embryonic vasculogenesis. Dev. Dyn.
218 (4), 663–670.
